Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4792384
Max Phase: Preclinical
Molecular Formula: C45H53FN8O9S2
Molecular Weight: 933.10
Molecule Type: Unknown
Associated Items:
ID: ALA4792384
Max Phase: Preclinical
Molecular Formula: C45H53FN8O9S2
Molecular Weight: 933.10
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cc1ncsc1-c1ccc(CNC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)C2(F)CC2)C(C)(C)SCCCCC(=O)NCCNc2cccc3c2C(=O)N(C2CCC(=O)NC2=O)C3=O)cc1
Standard InChI: InChI=1S/C45H53FN8O9S2/c1-25-36(64-24-50-25)27-12-10-26(11-13-27)22-49-38(58)32-21-28(55)23-53(32)42(62)37(52-43(63)45(46)16-17-45)44(2,3)65-20-5-4-9-33(56)48-19-18-47-30-8-6-7-29-35(30)41(61)54(40(29)60)31-14-15-34(57)51-39(31)59/h6-8,10-13,24,28,31-32,37,47,55H,4-5,9,14-23H2,1-3H3,(H,48,56)(H,49,58)(H,52,63)(H,51,57,59)/t28-,31?,32+,37-/m1/s1
Standard InChI Key: WYCPOGJRUAIBKU-JPQBYMPPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 933.10 | Molecular Weight (Monoisotopic): 932.3361 | AlogP: 3.00 | #Rotatable Bonds: 19 |
Polar Surface Area: 236.31 | Molecular Species: NEUTRAL | HBA: 13 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 17 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.00 | CX Basic pKa: 2.65 | CX LogP: 0.98 | CX LogD: 0.98 |
Aromatic Rings: 3 | Heavy Atoms: 65 | QED Weighted: 0.08 | Np Likeness Score: -0.62 |
1. Girardini M,Maniaci C,Hughes SJ,Testa A,Ciulli A. (2019) Cereblon versus VHL: Hijacking E3 ligases against each other using PROTACs., 27 (12.0): [PMID:30826187] [10.1016/j.bmc.2019.02.048] |
Source(1):